DA32 Life Science Tech Acquisition Corp. (DALS) 是一家上市公司 属于 金融服务 板块，经营于 壳公司 行业. 公司总部位于 New York City, NY, 美国. 现任CEO为 Steven Kafka.
DALS 拥有 IPO日期为 2021-07-28, 在 NASDAQ Capital Marke, 市值为 $264.2M.
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
